— Know what they know.
Not Investment Advice

GYRE Dividends

Gyre Therapeutics, Inc.
1W: +5.8% 1M: -12.8% 3M: +15.8% YTD: -4.1% 1Y: -20.1% 3Y: -12.9% 5Y: -87.3%
$6.53
+0.46 (+7.58%)
 
Weekly Expected Move ±6.0%
$5 $5 $6 $6 $7
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $692.4M mcap · 31M float · 0.365% daily turnover · Short 61% of daily vol
Credit Risk of going bust: lower than 83% of companies Debt: 0.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down 99.9%), Gyre Therapeutics, Inc. would be worth roughly what it owes.
Total debt $3.4M against a stock market value of $692.4M.
Distance to default 10.70 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.7M (short-term plus half of long-term), stock volatility 55.2%; Altman Z'' 4.26. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Dividend Overview

—%
Dividend Yield
$—
Annual Dividend
—%
Payout Ratio
—%
FCF Payout
0
Yr Increase Streak
—%
Buyback Yield
-0.08%
Total Return
—%
Chowder Number

Annual Dividend History

Full Payment History (3 payments)
Ex-DateAmountAdj. AmountYieldFrequency
2023-01-13 $0.2400 $3.6000 64230.77% Quarterly
2022-09-21 $1.4300 $21.4500 28600.00% Quarterly
2015-08-20 $0.5690 $896.1750 5927.08% Quarterly
Stock Split History (3 splits)
DateRatioType
2023-10-31 1:15 stock-split
2017-02-13 1:15 stock-split
2015-08-21 1:7 stock-split

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms